Ultragenyx Pharmaceutical Inc. (LON:0LIF)
London
· Delayed Price · Currency is GBP · Price in USD 39.50
+2.88 (7.86%)
At close: Jul 2, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Mepsevii | 30.35M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Mepsevii Growth | 12.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita | 134.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Growth | 69.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dojolvi | 88.19M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Dojolvi Growth | 22.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Collaboration Revenue in Profit-Share Territory | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Collaboration Revenue in Profit-Share Territory Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Royalty Revenue in European Territory | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Royalty Revenue in European Territory Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Royalty | 274.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Crysvita Royalty Growth | 23.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Daiichi Sankyo | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Daiichi Sankyo Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Evkeeza | 32.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Evkeeza Growth | 495.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
North America | 340.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 14.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 80.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 61.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America | 130.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Latin America Growth | 67.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia-Pacific | 8.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia-Pacific Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|